sábado, 10 de noviembre de 2018

JoPPP series on access to medicines, pricing, generics, biologics

JoPPP series on access to medicines, pricing, generics, biologics

Journal of Pharmaceutical Policy and Practice

JoPPP series on access to medicines, pricing, generics, biologics

Series Editors: Andy Gray, Fatima Suleman, Zaheer-Ud-Din Babar
The Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) provides a platform for researchers to disseminate empirical research findings, with the aim that people everywhere have access to the medicines they need and use them rationally. The Journal encompasses all aspects of pharmacy including policy development, clinical, social, administrative or economic, and provides a platform to researchers, academics and practitioners from around the world to share new evidence, concerns and perspectives.
To mark the 10th anniversary of its founding, the Journal is pleased to present a themed series on the broad topic of access to medicines, including papers that deal with medicine policy, pricing, access to generics and follow-on biologics (biosimilars), as well as high priced medicines in all settings.
  1. Content Type:Review

    Canadians have long been proud of their universal health insurance system, which publicly funds the cost of physician visits and hospitalizations at the point of care. Prescription drugs however, have been sub...
    Authors:Jaden Brandt, Brenna Shearer and Steven G. Morgan
    Citation:Journal of Pharmaceutical Policy and Practice 2018 11:28
    Published on: 

No hay comentarios: